Artfest International, Inc (fka ARTS)

[Suplex130]

Your comparing apple to oranges. INOL has a test that will be used worldwide by millions of patients. This company supposidly has a piece of artwork that they can't sell and is being bought with a shady agreement. They have an art network who has not released a fall schedule, and is in a market that is not that desierable. They have a sports memorbilla side that has an ok prospect, but even that doesn't have near the upside as a biotech. Sorry there just isn't anywhere close to the same oppurunity here. Plus the Share Structure here can hold this thing down on it's own. This thing is dilluted as hell and only continues to get bigger.